IFITM3 Rekombinanter Antikörper
IFITM3 Rekombinant Antikörper für WB, IF/ICC, FC (Intra), Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IF/ICC, FC (Intra), Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
242056C9
Kat-Nr. : 81135-3-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
81135-3-PBS bindet in WB, IF/ICC, FC (Intra), Indirect ELISA IFITM3 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | IFITM3 fusion protein Ag2285 |
| Vollständiger Name | interferon induced transmembrane protein 3 (1-8U) |
| Berechnetes Molekulargewicht | 133 aa, 15 kDa |
| Beobachtetes Molekulargewicht | 15-20 kDa |
| GenBank-Zugangsnummer | BC006794 |
| Gene symbol | IFITM3 |
| Gene ID (NCBI) | 10410 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
IFITM3, also named as interferon-inducible protein 1-8U, belongs to the CD225 family. It is IFN-induced antiviral protein that mediates cellular innate immunity to at least three major human pathogens, namely influenza A H1N1 virus, West Nile virus (WNV), and dengue virus, by inhibiting the early steps of replication. IFITM3 is identified as interferon-induced cellular proteins that restrict infections by retroviruses and filoviruses and of influenza virus and flaviviruses, respectively. IFITM3, the most potent antiviral IFITM, was found to inhibit an uncharacterized early infectious event after VSV endocytosis, but before primary transcription of its viral genome. IFITM proteins are viral restriction factors that can inhibit infection mediated by the influenza A virus (IAV) hemagglutinin (HA) protein. They differentially restrict the entry of a broad range of enveloped viruses, and modulate cellular tropism independently of viral receptor expression.









